OTCPK:SEMHF (Germany)
Â
Business Description
Siemens Healthineers AG
Description
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It also caters and earns revenue from Europe, the Middle East, Africa and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.18 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.17 | |||||
| Interest Coverage | 24.9 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.94 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.9 | |||||
| 3-Year EBITDA Growth Rate | 8.8 | |||||
| 3-Year EPS without NRI Growth Rate | 4.9 | |||||
| 3-Year FCF Growth Rate | 12.2 | |||||
| 3-Year Book Growth Rate | 21.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 90.15 | |||||
| 9-Day RSI | 81.42 | |||||
| 14-Day RSI | 74.06 | |||||
| 6-1 Month Momentum % | 0.69 | |||||
| 12-1 Month Momentum % | -25.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.11 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 97.49 | |||||
| Days Sales Outstanding | 64.21 | |||||
| Days Payable | 56.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.67 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | 6.7 | |||||
| Forward Dividend Yield % | 1.74 | |||||
| 5-Year Yield-on-Cost % | 1.67 | |||||
| 3-Year Average Share Buyback Ratio | -3.9 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.47 | |||||
| Operating Margin % | 13.47 | |||||
| Net Margin % | 9.39 | |||||
| ROE % | 11.53 | |||||
| ROA % | 4.54 | |||||
| ROIC % | 5.4 | |||||
| ROC (Joel Greenblatt) % | 73.96 | |||||
| ROCE % | 8.67 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.23 | |||||
| Forward PE Ratio | 25.83 | |||||
| PE Ratio without NRI | 30.23 | |||||
| Price-to-Owner-Earnings | 22.46 | |||||
| PEG Ratio | 4.8 | |||||
| PS Ratio | 2.88 | |||||
| PB Ratio | 3.11 | |||||
| Price-to-Free-Cash-Flow | 37.89 | |||||
| Price-to-Operating-Cash-Flow | 24.98 | |||||
| EV-to-EBIT | 20.25 | |||||
| EV-to-Forward-EBIT | 18.07 | |||||
| EV-to-EBITDA | 13.85 | |||||
| EV-to-Forward-EBITDA | 14.1 | |||||
| EV-to-Revenue | 2.72 | |||||
| EV-to-Forward-Revenue | 2.66 | |||||
| EV-to-FCF | 36.18 | |||||
| Price-to-Projected-FCF | 2.12 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.09 | |||||
| Earnings Yield (Greenblatt) % | 4.94 | |||||
| Forward Rate of Return (Yacktman) % | 7.84 |
How Siemens Healthineers AG (SEMHF) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SEMHF
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 23,162.393 | ||
| EPS (TTM) ($) | 1.917 | ||
| Beta | 0.9 | ||
| Volatility % | 34.43 | ||
| 14-Day RSI | 74.06 | ||
| 14-Day ATR ($) | 0.696666 | ||
| 20-Day SMA ($) | 53.8317 | ||
| 12-1 Month Momentum % | -25.14 | ||
| 52-Week Range ($) | 38.655 - 66.5 | ||
| Shares Outstanding (Mil) | 1,119.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Siemens Healthineers AG Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Siemens Healthineers AG Stock Events
| Event | Date | Price($) | Daily Change % | ||
|---|---|---|---|---|---|
| No Event Data | |||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||